Clinical Trials Results - National Cancer Institute

In English \| En español

Search


	Clinical Trials Search Results

Page Options

E-Mail This Search

Clinical Trial Questions?

Get Help:

1-800-4-CANCER

	Quick Links


	Help Using the NCI Clinical Trials Search Form Educational Materials About Clinical Trials About NCI's Cancer Clinical Trials Registry Dictionary of Cancer Terms NCI Drug Dictionary

View Content for:

Patients
Health Professionals

Display:

Title
Description with: Locations Eligibility
Full Trial Description
Custom

Results 1-23 of 23 for your search:

Drug:  calcium carbonate
Find trials that include:  Any drugs shown
Trial Status:  Closed

Hide Search Criteria

Show Search Criteria

Help with Results

Select All on Page Sort by: Show Results per Page

Vitamin D/Calcium Polyp Prevention Study

Phase: Phase III, Phase II
Type: Prevention
Status: Closed
Age: 45 to 75
Sponsor: NCI, Other
Protocol IDs: 5 R01 CA098286-03, NCT00153816

Phase III Randomized Study of Zoledronate in Patients With Bone Metastases Secondary to Prostate Cancer (Summary Last Modified 12/1999)

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: NOVARTIS-4244603039

Phase III Randomized Study of Zoledronate, Calcium, and Cholecalciferol (Vitamin D) to Prevent Bone Loss in Women With Breast Cancer Receiving Adjuvant Chemotherapy

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 40 and over
Sponsor: NCI
Protocol IDs: CALGB-79809, NCI-P01-0184, NCT00022087

Phase III Randomized Study of Calcium and Cholecalciferol With or Without Conjugated Estrogens and With or Without Risedronate for the Prevention of Osteoporosis in Patients With Prostate Cancer Receiving Androgen-Ablation Therapy

Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-N01C8, NCI-P02-0229, N01C8, NCT00043069

Phase III Hormone Therapy with FXM Plus Calcium Carbonate/Vitamin D and Calcitonin for Recurrent Breast Carcinoma with Osseous Metastases

Phase: Phase III
Type: Treatment
Status: Closed
Age: postmenopausal
Sponsor:
Protocol IDs: CBCG-4400

Phase III Randomized Study of Risedronate For Prevention of Bone Loss in Premenopausal Women Undergoing Chemotherapy For Primary Breast Cancer

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-N02C1, N02C1, NCT00054418

Effects of Zometa and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast Cancer

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 40 to 55
Sponsor: Other
Protocol IDs: 1769-03-A, CZOL446E, NCT00202059

A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors

Phase: Phase III
Type: Supportive care
Status: Closed
Age: Not specified
Sponsor: Other
Protocol IDs: BONEII, NCT00186901

Phase III Randomized Study of Zoledronate in Preventing Osteoporosis and Associated Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiotherapy and Luteinizing Hormone-Releasing Hormone Agonist Therapy

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-0518, 0518, NCT00329797

10.

Chemoprevention of Colorectal Adenomas

Phase: Phase III
Type: Prevention
Status: Closed
Age: 40 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: COLO CP-01-US, NCT00486512

11.

Women's Health Initiative (WHI)

Phase: Phase III
Type: Health services research, Natural history/Epidemiology, Prevention
Status: Completed
Age: 50 to 79
Sponsor: NCI, NHLBI
Protocol IDs: 114, NCT00000611

12.

Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial CAN-NCIC-MA27

Phase: Phase III
Type: Natural history/Epidemiology, Supportive care
Status: Closed
Age: 45 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000483099, CAN-NCIC-MA27B, SWOG-NCIC-MA27B, NCCTG-NCIC-MA27B, CAN-NCIC-BONE, NCT00354302

13.

Phase II Chemoprevention Study of Vitamin D3 and Calcium for Colorectal Cancer (Summary Last Modified 01/98)

Phase: Phase II
Type: Prevention
Status: Closed
Age: Over 18
Sponsor: NCI
Protocol IDs: CPMC-IRB-6850, NCI-P97-0109

14.

Phase II Double Blind, Randomized, Placebo Controlled, Chemoprevention Study of Calcium Carbonate in Combination with Vitamin D versus Placebo in Patients with Colorectal Polyp Growth (Summary Last Modified 02/1999)

Phase: Phase II
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CPMC-IRB-94087, NCI-P97-0111

15.

Phase II, Randomized, Placebo-Controlled Study of Dietary Calcium for Prevention of Recurrent Neoplastic Polyps in the Large Bowel in Patients with a History of Large Bowel Adenoma (Summary Last Modified 09/92)

Phase: Phase II
Type: Prevention
Status: Closed
Age: 21 to 80
Sponsor:
Protocol IDs: DMS-CALCIUM/CRC, NCI-P92-0017

16.

Calcium, Vitamin D, and Colon Cancer Risk Biomarkers

Phase: Phase II
Type: Prevention
Status: Closed
Age: 30 to 74
Sponsor: NCI, Other
Protocol IDs: 0126-2004, 5 R01 CA104637-02, NCT00208793

17.

Phase I Study of Two Calcium Compounds in Patients with Previously Resected Dukes' Stages A/B/C Adenocarcinoma of the Colon (Summary Last Modified 03/93)

Phase: Phase I
Type: Prevention
Status: Closed
Age: 30 to 80
Sponsor:
Protocol IDs: MDA-DM-90046, NCI-P93-0036

18.

Effect of Vitamin D and Calcium on Genes in the Colon

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 48 to 72
Sponsor: Other
Protocol IDs: RUH IRB # PHO-0554, NCT00298545

19.

Hormonal Therapy with Fluoxymesterone plus Salmon Calcitonin for Breast Cancer Metastatic to Bone and Soft Tissue

Phase: No phase specified
Type: Treatment
Status: Closed
Age: postmenopausal
Sponsor:
Protocol IDs: CBCG-4401

20.

Randomized, Double-Blind Study of Dietary Calcium in the Prevention of Neoplastic Polyps in the Large Bowel in Patients with a Recent History of These Tumors (Summary Last Modified 06/96)

Phase: No phase specified
Type: Prevention
Status: Closed
Age: 21 to 79
Sponsor:
Protocol IDs: DMS-CPHS-11521, NCI-P89-0021

21.

Pilot Randomized Study of Calcium for Chemoprevention of Colorectal Adenomas and New Primary Carcinomas in Surgically Treated Patients (Summary Last Modified 03/1999)

Phase: No phase specified
Type: Prevention
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: SWOG-9041, NCI-P92-0031

22.

Randomized, Placebo-Controlled Study of Calcium Carbonate for Chemoprevention of Colorectal Epithelial Cell Hyperproliferation in Patients with a History of Adenomatous Colonic Polyps (Summary Last Modified 03/93)

Phase: No phase specified
Type: Prevention
Status: Completed
Age: 30 to 74
Sponsor:
Protocol IDs: UMN-RO1CA51932, NCI-P93-0037

23.

Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density

Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: SUNY UMU IRB # 4689, NCT00145704

Select All on Page

Help with Results

A Service of the National Cancer Institute